**Core tip:** Excessive alcohol consumption remains one of the most important causes of liver disease worldwide. Alcoholic steatosis results from the deposition of fat in liver cells and is the earliest stage of alcohol-related liver disease. Usually inflammation is associated with steatohepatitis, however our results demonstrate that chronic ethanol exposure increased the expression of the inflammatory gene interleukin-1b. Paradoxically the expression of adiponectin receptor-2 and sirtuin-1 also increased for attenuating the liver injury. Ultrastructural abnormalities were observed showing early alterations in liver cells. Knowledge of alcohol injury mechanisms will contribute to the development of novel therapies in the treatment of alcoholic liver disease.

INTRODUCTION
============

Alcoholic liver disease (ALD) encompasses a wide spectrum of injury, ranging from simple steatosis, leading to steatohepatitis, fibrosis and finally to cirrhosis\[[@B1],[@B2]\]. Hepatic steatosis is the first and most common consequence of alcohol abuse, develops in about 90%-95% of individuals who drink heavily, is usually asymptomatic and self limited; but may also occur in individuals who drink moderately\[[@B2]\]. Several studies have suggested that progression to more severe liver disease occurs in about 5%-20% of alcohol consumers\[[@B1]\]. As a consequence, it is important to better understand the pathogenesis of hepatic steatosis and the relationship between steatosis and liver injury.

Excessive accumulation of triglycerides in hepatocytes is the hallmark of hepatic steatosis. The source of triglyceride in the liver of ethanol consumers may be originated from disturbances of fatty acid oxidation mechanisms, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, alterations in lipogenic and lipolytic pathways and immune responses to ethanol\[[@B3]-[@B7]\]. A number of molecular mediator pathways regulating the synthesis, export, and oxidation of lipids have been discovered to be altered by ethanol: Sterol regulatory element-binding proteins, peroxisome proliferator-activated receptors alpha and gamma, adiponectin, sirtuins and others\[[@B8]\].

Zebrafish is increasingly used as an *in vivo* model system for translational research, since zebrafish have a high degree of genetic conservation and their morphological and molecular basis of tissue and organ development is either identical or similar to other vertebrates including humans\[[@B9],[@B10]\]. In previous studies regarding to hepatic diseases related to ethanol, zebrafish proved to be a valuable strategy for identifying lipogenic mechanisms, genes and pathways that influence hepatic steatosis\[[@B11]-[@B14]\]. Studies focused in inflammatory pathways in steatosis are scarce and the issue is not completely elucidated. Chronic ethanol consumption results in the activation of innate immunity and an inflammatory state, which contributes to the pathogenesis of ethanol-induced liver injury. The expression of tumor necrosis factor - alpha (*tnf-a*), interleukin-1b (*il-1b*), interleukin-10 (*il-10*), adiponectin, adiponectin receptor 2 (*adipor2*) and sirtuin-1 (*sirt-1*) were evaluated and histological and ultrastructural evaluations were performed in liver of adult zebrafish after chronic ethanol exposure.

MATERIALS AND METHODS
=====================

Animal care and use statement
-----------------------------

Wild-type, adult zebrafish (*Danio rerio*), male and female, were purchased from a commercial distributor (Fish Flower, Porto Alegre, RS). The animals were of heterogeneous wild type stock from the standard short-fin phenotype and were housed for 2 wk before the experiments in order to acclimate to the laboratory facility. The animal protocol was designed to minimize pain or discomfort to the animals. Fish were maintained in aerated water at 28 °C ± 2 °C, 6.8-7 pH, on a 12/12 light/dark photoperiod cycle (lights on at 7:00 am). Biochemical parameters and quality of the water were monitored regularly: pH, presence of nitrates and nitrites, oxygen and ammonia levels. The animals were fed twice a day with fish food until satiety. Experiments were performed using a total of 104 animals. All fish used in this study were healthy and free of any signs of disease.

After acclimation period, the fish were randomly allocated into experimental tanks, density of 1 fish per liter of water. The following groups were performed (*n* = 52/group): Control (C) and ethanol (E). E group received 0.5% (v/v) of ethanol (Merck KGaA, Germany) directly added into water; tank water was changed every two days and the ethanol replaced\[[@B15]\]. This ethanol dose was chosen due to the liver damage observed by Schneider and coworkers in zebrafish exposed to 0.5% of ethanol\[[@B15]\]. The tank water of C group was also changed in same days of E group. At 2 and 4 wk, fish were euthanized by hypothermal shock\[[@B16]\] and livers were completely removed for molecular and histological analysis.

The protocols were approved by the Research Ethics Committee of Hospital de Clínicas de Porto Alegre, Brazil (No. 10.0327), and conducted in accordance with international guidelines for the care and use of laboratory animals.

Histological analysis
---------------------

Livers of zebrafish dissected at 2^nd^ and 4^th^ weeks were stained with hematoxylin and eosin (*n* = 5/group) or Oil Red (*n* = 5/group). Livers were fixed in 10% formalin, embedded in paraffin wax, sectioned (5 μm), and slices were stained with hematoxylin and eosin. Livers embedded in Tissue-Tek OCT Compound (Sakura Finetek, United States) were cryosectioned (8 μm thick) and stained with Oil Red (Sigma-Aldrich, United States) to assess fatty droplet accumulation.

For ultrastructural evaluation, livers of 2 animals (male) of each group (C and E) were fixed in 2.5% glutaraldehyde diluted by 0.12 mol/L phosphate buffer (pH 7.2-7.4) for 3 h at 4 °C. The material was washed three times in the same buffer at 30-min intervals and then post-fixed for 30 min in 1% buffered osmium tetroxide followed by a phosphate buffer (0.1 mol/L) wash three times at 15-min intervals. Livers were dehydrated using ascending grades of alcohols and embedded in an epon-araldite mixture. Ultrathin sections (90 nm) were stained with 2% uranyl acetate and 1% lead citrate\[[@B17]\]. The ultrathin sections were examined under JEM 1200 FX II transmission electron microscope.

Gene expression assessment
--------------------------

The liver samples (pool = 3 livers; *n* = 5/group/period) were immediately immersed in liquid nitrogen and stored in ultrafreezer (-80 °C). Total RNA was extracted using the TRIzol reagent (Invitrogen, United States) according to the manufacturer's protocol and the concentrations were quantified by Nanodrop (Thermo Fisher Scientific, United States) at 260 nm. RNA purity was verified by a 260/280 nm ratio of 1.8 or greater. First-strand cDNA was synthesized from 3 µg of total RNA using the Superscript ^TM^ II RT system (Invitrogen, United States). Gene expression analysis of *adiponectin*, *adipor2*, *sirt-1, tnf-a, il-1b* and *il-10* were performed from 5 μL of cDNA and run in duplicate using TaqMan Gene Expression Assays (Life Technologies, United States) (Table [1](#T1){ref-type="table"}).

###### 

Primers and probes identification assays

  **Gene**                                     **Assay ID**
  -------------------------------------------- --------------------------------------------
  *adiponectin*                                F: 5'-AGG CTT AGA CTG TGA ACG GTG GGA C-3'
  R: 5'-AGC AGG TGT GTC CAG ATG TTT CCA G-3'   
  *adipor2*                                    dr0342657
  *sirt-1*                                     ENSDART00000098209
  *tnf-a*                                      dr03126848
  *il-1b*                                      dr03114368
  *il-10*                                      dr03103209
  *ef-1α*                                      dr03432748

*tnf-a*: Tumor necrosis factor-alpha; *il*: Interleukin; *adipor2*: Adiponectin receptor 2; *sirt-1*: Sirtuin-1; *ef-1*α: Elongation factor-α gene.

PCR amplifications were run on a Step One™ Real time PCR System (Applied Biosystems, United States) and performed starting with a 2 min denaturation step at 50 °C, 10 min at 95 °C followed by 40 cycles with 15 s at 95 °C and 1 min at 60 °C.

Gene expression was quantified using the 2^-ΔΔCt^ (threshold cycle) method and normalization was done using the *elongation factor-*α *gene* (*ef-1*α).

Statistical analysis
--------------------

Log-transformed data was tested with Kruskal-Wallis test and Dunn as *post hoc* test for multiple comparisons. Results with *P* \< 0.05 were considered statistically significant. All analysis were performed using the Statistical Package for the Social Sciences (SPSS 18.0) software.

RESULTS
=======

Ethanol effects on zebrafish liver histology
--------------------------------------------

Sections of livers from control animals stained with hematoxylin-eosin showed well-preserved liver cells without signs of fat deposits (Figure [1A](#F1){ref-type="fig"}). After 2 wk of ethanol exposure, the liver appearance of animals from E group were similar to the C group (Figure [1B](#F1){ref-type="fig"}), however at 4 wk, the hepatocytes of animals from E group showed an expressive enlargement and presented nuclei displaced to the periphery of the cytoplasm due to fatty infiltration (Figure [1C](#F1){ref-type="fig"}). Livers of the control animals stained with Oil Red did not present any lipid droplets (Figure [2A](#F2){ref-type="fig"}). However, ethanol-treated animals presented a light steatosis at 2^nd^ week (Figure [2B](#F2){ref-type="fig"}) which increased severely in the 4^th^ week (Figure [2C](#F2){ref-type="fig"}).

![Hematoxylin-eosin staining of liver sections from zebrafish. A: C group (2 wk), the hepatocytes are aligned in cords, absence of fat droplets; B: E group (2 wk), without apparent changes compared with the C group; C: E group (4 wk), enlarged hepatocytes due to fatty infiltration. Magnification: 400 ×.](WJH-9-418-g001){#F1}

![Oil red staining sections of zebrafish liver. A: C group (4 wk), absence of lipid droplets; B: E group (2 wk), mild presence of lipid droplets; C: E group (4 wk), intense lipid accumulation induced by ethanol in hepatocytes. Magnification: 400 ×.](WJH-9-418-g002){#F2}

The supplemental file contains the results of ultrastructural evaluations. Control group showed hepatocytes with hexagonal shape, evident nucleoli of moderate size and located in the centre of the spherically shaped nuclei (Figure [3A](#F3){ref-type="fig"}), intracellular duct with microvilli (Figure [3C](#F3){ref-type="fig"}), rough endoplasmic reticulum (RER) contained few cisternae and were closely associated with mitochondria (Figure [3E](#F3){ref-type="fig"}). Compared to control group, hepatocytes of ethanol-treated fish showed a large amount of glycogen associated with numerous lipid droplets (Figure [3B](#F3){ref-type="fig"}); the intracellular canaliculi often showed signs of degeneration with aspects of myelin figures therein (Figure [3D](#F3){ref-type="fig"}); and augmented number of RER cisterns (Figure [3F](#F3){ref-type="fig"}).

![Electron micrographs of liver sections of control (A, C and E) and ethanol exposed groups (B, D and F). A: Polygonal hepatocytes (H), spherical nucleus (n) sinusoid (s), endothelial cell (ec); B: Presence of large amount of glycogen (g) and lipid droplets (ld) in the hepatocytes cytoplasm; C: Intracellular canaliculus with large number of microvilli (a) within; E: It is noted the parallel arrangement of rough endoplasmic reticulum (rer) around the core; D: Myelin figure (mf) inside an intracellular canaliculus; F: Rough endoplasmic reticulum (rer) composed by 8-12 parallel cisterns; H: Hepatocytes; ec: Endothelial cell.](WJH-9-418-g003){#F3}

Gene expression assessment
--------------------------

At 2^nd^ week the genes evaluated did not present statistical difference in mRNA expression between E and C groups, except for *tnf-a*, which was decreased. An increase of expression of *tnf-a, il-1b, adipor2* and *sirt-1* was observed between two and four weeks in E group, demonstrating that time to ethanol exposure had influence on expression of these genes. The *il-10* expression did not reach significant statistical difference between groups at any period (data not shown). *Adiponectin* mRNA was not detected in liver of animals from C and E groups.

The effect of ethanol on the expression of cytokines mRNA
---------------------------------------------------------

The hepatic *tnf-a* expression in E group was lower than in C group at 2 wk (*P* = 0.018). The *il1-b* expression was significantly increased between C and E groups at 4^th^ week (*P* = 0.024) (Figure [4](#F4){ref-type="fig"}).

![Effect of ethanol on mRNA liver expression of tumor necrosis factor-alpha and interleukin-1b. *tnf-a* was decreased significantly in E group compared to C at 2^nd^ week (*P* = 0.018) and increased along time up 4^th^ week (*P* \< 0.001), reaching C group levels. *Il1-b* expression increased between 2 and 4 wk (*P* = 0.001) and at 4^th^ week there was a significant difference between C and E groups (*P* = 0.024). Statistical data were determined by the Kruskal-Wallis test and Dunn as post hoc test. Values significantly different where indicated: ^a^Significant statistical difference between 2 and 4 wk; ^b^Significant statistical difference between C and E groups. *P* \< 0.05 was considered. *tnf-a*: Tumor necrosis factor-alpha; *il*: Interleukin.](WJH-9-418-g004){#F4}

Ethanol effects on mRNA expression of adipor2 and sirt-1
--------------------------------------------------------

The expression of *adipor2* increased in E group between 2 and 4 wk (*P* \< 0.0001) and was higher in E compared to C group (*P* = 0.006) at 4^th^ week (Figure [5](#F5){ref-type="fig"}). *Sirt-1* showed an increased expression in E group along time until the 4^th^ week (*P* = 0.001) (Figure [5](#F5){ref-type="fig"}).

![Effect of ethanol on mRNA liver expression of adiponectin receptor 2 and sirtuin-1 of zebrafish. *adipor2* and *sirt-1* expression increased in E group between 2 and 4 wk; *P* \< 0.0001 and *P* = 0.001, respectively. At 4^th^ week *adipor2* of E group was increased compared to C, *P* = 0.006. ^a^Significant statistical difference between C and E groups; ^b^Significant statistical difference between 2 and 4 wk. *P* \< 0.05 was considered significant. *adipor2*: Adiponectin receptor 2; *sirt-1*: Sirtuin-1.](WJH-9-418-g005){#F5}

DISCUSSION
==========

Hepatic metabolic derangements are key components in the development of steatosis, considered the first hit for development of ALD. Until recently, the role of inflammation was linked to the presence of steatohepatitis, and scarce evidences have shown the precocity of inflammatory signaling during steatosis\[[@B18]\].

Important histological and ultrastructural abnormalities in liver of chronic ethanol-exposed zebrafish were seen at 4^th^ week in this study. A light steatosis was detected by oil red staining at 2^nd^ week, which increased severely at 4^th^ week. Electron transmission microscopy revealed concurrent marked accumulation of glycogen and lipid droplets in cytoplasm, committed intracellular canaliculi, and increased RER cisterns. Our findings were similar to those described in alcoholic humans: Increased glycogen and fat deposits in the cytoplasm, abnormalities in endoplasmic reticulum\[[@B19]\]. Howarth et al\[[@B13]\] observed abnormalities of endoplasmic reticulum and biliary canaliculi in acutely ethanol treated zebrafish larvae. Mitochondrial and ER abnormalities were seen in a model of non-alcoholic fatty liver disease (NAFLD) induced by fructose in zebrafish\[[@B20]\].

In accordance to histological findings, there were changes in hepatic mRNA expression of *il-1b, tnf-a, sirt-1* and *adipor2*. At fourth week, in the presence of more advanced steatosis, *il-1b* showed an expressive increase. Growing evidence indicates that increased pro-inflammatory cytokines are involved in the progression of alcohol-induced liver injury\[[@B21],[@B22]\]. The activation of innate immunity also stimulates the release of hepatoprotective and anti-inflammatory cytokines, which play a compensatory role against liver damage and inflammation\[[@B22]\]. In our study the *il-10* expression was not different between C and E groups. *The il-10* is produced by macrophages, lymphocytes, and Kupffer cells, and the liver is considered to be the main source of *il-10* production in response to lipopolysaccharides (LPS) stimulation\[[@B23]\]. Sepulcre et al\[[@B24]\] demonstrated that zebrafish responds to LPS with much lower sensitivity than mammals, what can explain the absence of difference in hepatic expression of *il-10*, between C and E groups.

Elevated circulating levels of *TNF-*α and *IL-1b* have been observed in human patients and animal models of ethanol-induced liver injury\[[@B25],[@B26]\]. The expression levels of these cytokines correlate well with the progression of the disease. In our study the *tnf-a* liver expression was initially decreased in E group compared to C at 2^nd^ week and increased significantly along 2^nd^ and 4^th^ week, reaching the C expression levels at 4^th^ week. Liu et al\[[@B27]\] demonstrated that only zebrafish with previous intestinal inflammation presented elevated *tnf-a* expression in liver compared to healthy animals after LPS exposure. Zebrafish are indeed able to respond to LPS, however with much lower sensitivity than mammals and *via* a *tlr4/myd88*-independent signaling pathway\[[@B24],[@B28]\]. Among the few studies that evaluated *tnf-a* expression in the liver of zebrafish, Sapp observed an elevation of *tnf-a* in fructose-treated larvae and Hammes in thiocetamide-treated fish\[[@B20],[@B29]\]. Although there was no direct evidence in our study, these cited findings conducted us to the following conclusions: *tnf-a* is not promptly induced by LPS in zebrafish exposed to ethanol as occurring in mammals and its activation mechanism seems to be associated to more aggressive hepatotoxicants.

Differently, the hepatic expression of *il-1b* increased significantly over the period considered and at 4^th^ week it was significantly higher in E group compared to C. *Interleukin-1*, the "gatekeeper" of inflammation, is the apical cytokine in a signaling cascade that drives the early responses to injury or infection\[[@B30]\]. *Il-1b* production requires caspase-1 activation by inflammasomes-multiprotein complexes that are assembled in response to danger signals. Vojtech et al\[[@B31]\] have described the cleavage of zebrafish *il-1b* by the caspase-1 homologues caspase-A and caspase-B, implying that the basic facets of the inflammasome platform of immune activation are conserved in zebrafish. The induction of *il-1b* demonstrated an early response to inflammatory stimuli in the present study. The up regulation of *il-1b* did not occur synergistically with *tnf-a* expression, as seen in mammals with ALD\[[@B26]\]. This result may suggest that *il-1b* is up regulated during chronic alcohol induced steatosis in zebrafish in a LPS independent pathway.

Adiponectin is a hormone that is secreted exclusively by adipocytes and has anti-inflammatory and hepatoprotective activities\[[@B32]\]. Circulating adiponectin is decreased in mammals with alcoholic disease\[[@B32],[@B33]\]. In our study, *adiponectin* mRNA did not amplify in the livers of animals of both groups. Amali and collaborators observed elevated expression of *adiponectin* in liver of zebrafish treated with thioacetamide, but not in control animals\[[@B34]\].

In this study, the *adipor2*, a receptor of adiponectin, was over expressed in liver of animals exposed to ethanol, during the period that hepatic steatosis became more severe. To date, very few data are available regarding the effect of chronic ethanol exposure on hepatic *adipor2*. Hammes et al\[[@B29]\] observed decreased mRNA expression of hepatic *adipor2* and *sirt-1* and increased *tnf-a* in a model of NAFLD induced by thioacetamide in zebrafish. Possibly, thioacetamide, a more aggressive liver toxicant, contributed to down regulate *adipor2*. In humans, it was observed by Kaser that in presence of nonalcoholic steatohepatitis, *adiponectin receptor 2* expression was decreased compared to simple steatosis\[[@B35]\]. Neumeier et al\[[@B36]\] showed that animals (rodents) with liver steatosis presented elevated liver expression of *adipor2*. The increased expression of *adipor2* may be related to hepatic protection during steatosis.

*SIRT-1* is a NAD^+^-dependent class III protein deacetylase that regulates lipid metabolism by deacetylation of modified lysine residues on histones, and targets a number of transcription factors involved in the regulation of gluconeogenesis, mitochondrial biogenesis, resistance to oxidative stress, adipogenesis and lipolysis, glycolysis, inflammation, apoptosis, cell differentiation, and angiogenesis\[[@B37]\]. To date, little is known about the function of *SIRT-1* in innate immunity and host defense. Studies in mammals have indicated that *SIRT-1* suppresses innate inflammatory responses\[[@B38]\]. Other authors have shown an expressive increase of *sirt-1* in liver of zebrafish chronically exposed to ethanol (0.5% vv)\[[@B39],[@B40]\]. In our study occurred a significant increase of *sirt-1* between second and fourth weeks in fish treated with ethanol. We can speculate that the *sirt-1* hepatoprotective role might be involved in this process.

Ethanol effectively induced hepatic lipid accumulation and ultrastructural abnormalities in liver of zebrafish. Augmented expression of *il-1b* suggests that inflammatory signaling plays a significant role in hepatic steatosis and *adipor2* and *sirt-1* increased expression appears to represent compensatory efforts to alleviate consequences of ethanol liver injury, probably, indicating a hepatoprotective reaction. Hepatic steatosis is considered the first hit of chronic progressive ALD. The investigation of earliest events linked to ALD requires multiple strategies to reverse the damage effects of ethanol to the liver and to contribute to development of new therapies.
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Background
----------

Alcohol abuse is an acute health problem throughout the world and alcohol consumption is related to the occurrence of chronic liver disease. Hepatic steatosis is the first step of liver damage, and in spite of being considered a benign event, may progress to alcoholic steatohepatitis and more severe liver disease. The zebrafish has been proposed for the study of the effects of ethanol on several organs and has been helpful to unravel the pathways of liver damage by alcohol.

Research frontiers
------------------

The zebrafish (*Danio rerio*) is increasingly recognized as an important model system for studying liver development and human liver disease. Despite differences in the anatomical architecture of the zebrafish liver from mammals, alcoholic liver damages are similar to those of human beings, including alcoholic steatosis. This animal model will likely be a useful tool to further elucidate the pathogenesis and related disorders of alcoholic liver disease, as well as to discover new treatments.

Innovations and breakthroughs
-----------------------------

Proinflammatory cytokines were frequently linked to steatohepatitis, however, this study describes early ultrastructural alterations in hepatocytes and cytokines increase in the onset of ethanol-induced liver damage.

Applications
------------

The major advantage of zebrafish as a model system for hepatic processes is the ability to perform screening (genetic or chemical) in a vertebrate organism. The investigation of earliest events linked to alcoholic liver disease can contribute to the development of new strategies to prevent the advance of such disease.

Terminology
-----------

Hepatic steatosis: Or fatty liver. It is caused by an excessive fat deposition in the liver; Steatohepatitis: It is a type of fatty liver disease characterized by the presence of inflammation; Fibrosis: Scars produced in a reparative or reactive process in the liver; Ultrastructure: The detailed structure of a biological specimen, such as a cell, that can be observed by electron microscopy; Histology: The study of the microscopic anatomy of tissues. The cell of the tissue can be observed under a light microscope.
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